Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16409 |
OSMI-1
|
Others; Acyltransferase | Metabolism; Others |
OSMI-1 是一种 O-GlcNAc 转移酶 (OGT) 抑制剂 (IC50=2.7 μM),具有口服活性和细胞渗透性。OSMI-1 可以抑制蛋白质 O-GlcNA 酰化,而不会定性地改变细胞表面 N- 或 O- 连接的聚糖。 | |||
T63988 | (Rac)-OSMI-1 | ||
(Rac)-OSMI-1 是 OSMI-1 的外消旋体。其中 OSMI-1 是 O-GlcNAc 转移酶 (OGT) 抑制剂 (IC50: 2.7 μM)。OSMI-1 对哺乳动物细胞系中的蛋白 O-连接的 N-乙酰氨基葡萄糖 (O-GlcNAcylation) 具有抑制作用,且不会定性地改变细胞表面 N-或 O-连接的聚糖。 | |||
T36577 |
K-Biotin-W-Histone H2B (108-125) (trifluoroacetate salt)
K-Biotin-W-Histone H2B (108-125) (trifluoroacetate salt) |
||
Histone H2B (108-125) is a peptide fragment of histone H2B that corresponds to amino acid residues 109-126 of the human histone H2B sequence. It contains an N-terminal biotinylated lysine followed by a tryptophan linker. Histone H2B can be modified by addition of an O-linked N-acetylglucosamine (GlcNAc) moiety to the serine residue at position 112, which promotes monoubiquitination of the lysine at position 120.1 Both of these modifications are associated with active transcription. Histone H2B a... |